FEBS Letters | |
Processing of proendothelin‐1 by human furin convertase | |
Sawamura, Tatsuya1  Claing, Audrey2  Leduc, Richard2  Masaki, Tomoh1  Kido, Tsuneo1  D'Orléans-Juste, Pedro2  Denault, Jean-Bernard2  | |
[1] Department of Pharmacology, Medical School, Kyoto University, Kyoto 606, Japan;Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Québec, J1H 5N4, Canada | |
关键词: Endothelin-1; Precursor processing; Furin; Convertase; Proteolytic inhibition; Endothelial cell; | |
DOI : 10.1016/0014-5793(95)00249-9 | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
【 摘 要 】
Endothelin-1 (ET-1) is the most potent vasoactive peptide known to date. The peptide is initially synthesized as an inactive precursor (proET-1) which undergoes proteolysis at specific pairs of basic amino acids to yield bigET-1. Production of ET-1 then proceeds by cleavage of bigET-1 by the endothelin converting enzyme (ECE). Here, we demonstrate that the in vitro cleavage of proET-1 by furin, a mammalian convertase involved in precursor processing, produced bigET-1. Upon further processing, bigET-1 was converted to biologically active ET-1. Furthermore, we demonstrate that the furin inhibitor, decanoyl-Arg-ValLys-Arg chloromethylketone, abolished production of ET-1 in endothelial cells.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020300917ZK.pdf | 555KB | download |